NO903455L - Analoger av frigjoeringshormon for luteiniserende hormon samt fremstilling derav. - Google Patents

Analoger av frigjoeringshormon for luteiniserende hormon samt fremstilling derav.

Info

Publication number
NO903455L
NO903455L NO90903455A NO903455A NO903455L NO 903455 L NO903455 L NO 903455L NO 90903455 A NO90903455 A NO 90903455A NO 903455 A NO903455 A NO 903455A NO 903455 L NO903455 L NO 903455L
Authority
NO
Norway
Prior art keywords
hormon
lute
analogs
inhibiting
preparation
Prior art date
Application number
NO90903455A
Other languages
English (en)
Other versions
NO903455D0 (no
Inventor
Fortuna Haviv
Jonathan Greer
Original Assignee
Tap Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tap Pharmaceuticals Inc filed Critical Tap Pharmaceuticals Inc
Publication of NO903455D0 publication Critical patent/NO903455D0/no
Publication of NO903455L publication Critical patent/NO903455L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Nye "pseudo" nonapeptid og decapeptidderivater av LHRH. Mer spesielt beskrives derivater av LHRH hvor nitrogenatomet av minst en av amidbindingene har blitt alkylert.
NO90903455A 1989-08-07 1990-08-06 Analoger av frigjoeringshormon for luteiniserende hormon samt fremstilling derav. NO903455L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39057289A 1989-08-07 1989-08-07
US07/548,512 US5110904A (en) 1989-08-07 1990-07-10 Lhrh analogs

Publications (2)

Publication Number Publication Date
NO903455D0 NO903455D0 (no) 1990-08-06
NO903455L true NO903455L (no) 1991-02-08

Family

ID=27013204

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90903455A NO903455L (no) 1989-08-07 1990-08-06 Analoger av frigjoeringshormon for luteiniserende hormon samt fremstilling derav.

Country Status (12)

Country Link
US (1) US5110904A (no)
EP (1) EP0413209A1 (no)
JP (1) JPH03101695A (no)
KR (1) KR0144144B1 (no)
AU (2) AU6028690A (no)
CA (1) CA2022444C (no)
HU (1) HUT54387A (no)
IE (1) IE902740A1 (no)
IL (1) IL95136A0 (no)
NO (1) NO903455L (no)
PL (1) PL286388A1 (no)
PT (1) PT94924B (no)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8713240D0 (en) * 1987-06-05 1987-07-08 Proteus Biotech Ltd Hormones
US5300492A (en) * 1988-02-10 1994-04-05 Tap Pharmaceuticals LHRH analogs
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
US5686410A (en) * 1989-07-20 1997-11-11 Novartis Ag Polypeptide derivatives
DE3936328A1 (de) * 1989-10-27 1991-05-02 Schering Ag Pharmazeutische praeparate
US5352796A (en) * 1989-10-30 1994-10-04 The Salk Institute For Biological Studies Amino acids useful in making GnRH analogs
US5296468A (en) * 1989-10-30 1994-03-22 The Salk Institute For Biological Studies GnRH analogs
EP0477499B1 (de) * 1990-08-04 1994-01-26 Hoechst Aktiengesellschaft Gonadoliberin-Antagonisten
US5744450A (en) 1991-03-14 1998-04-28 The Salk Institute For Biological Studies GnRH analogs
JP2719233B2 (ja) * 1991-04-25 1998-02-25 デゲンギ，ロマノ 黄体形成ホルモン放出ホルモン拮抗ペプチド
JPH06509075A (ja) * 1991-07-01 1994-10-13 ユニヴァーシティ　テクノロジーズ　インターナショナル　インコーポレイテッド ＧｎＲＨ及び他の生物学的に活性なリガンドの非感度低下性類縁体
US5480969A (en) * 1992-09-15 1996-01-02 The Administrators Of The Tulane Educational Fund Antagonists of LHRH
JPH08504209A (ja) * 1992-12-04 1996-05-07 アボツト・ラボラトリーズ ６位修飾デカペプチドｌｈｒｈ拮抗薬
UA61046C2 (en) * 1992-12-07 2003-11-17 Takeda Chemical Industries Ltd Sustained-release preparation and method for its manufacture
TW333456B (en) * 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
IL108509A0 (en) * 1993-02-22 1994-05-30 Salk Inst For Biological Studi GnRH antagonist peptides
US5413990A (en) * 1993-08-06 1995-05-09 Tap Pharmaceuticals Inc. N-terminus modified analogs of LHRH
US5502035A (en) * 1993-08-06 1996-03-26 Tap Holdings Inc. N-terminus modified analogs of LHRH
JP3662926B2 (ja) * 1993-08-06 2005-06-22 タツプ・ホールデイングス・インコーポレイテツド Ｌｈｒｈのｎ末端改変類似体
CA2143044C (en) * 1994-02-21 2005-04-12 Yasutaka Igari Matrix for sustained-release preparation
US5508383A (en) * 1994-03-09 1996-04-16 Tap Holdings Inc. Cyclic peptide LHRH antagonists
US5516759A (en) * 1994-12-08 1996-05-14 Tap Holdings Inc. LHRH antagonists having lactam groups at the N-terminus
US5681928A (en) * 1994-12-16 1997-10-28 The Salk Institute For Biological Studies Betides and methods for screening peptides using same
WO1996022786A1 (en) * 1995-01-23 1996-08-01 Takeda Chemical Industries, Ltd. Sustained-release preparation and use
US5843901A (en) 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
DE19544212A1 (de) * 1995-11-28 1997-06-05 Asta Medica Ag Neue LH-RH-Antagonisten mit verbesserter Wirkung
US5780435A (en) * 1995-12-15 1998-07-14 Praecis Pharmaceuticals Incorporated Methods for treating prostate cancer with LHRH-R antagonists
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
US5710247A (en) * 1996-03-19 1998-01-20 Abbott Laboratories Process and intermediates for the synthesis of LHRH antagonists
US5710246A (en) * 1996-03-19 1998-01-20 Abbott Laboratories Process for intermediates for the synthesis of LHRH antagonists
EP0842946A1 (en) * 1996-11-14 1998-05-20 Laboratoire Theramex S.A. Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them
US5968895A (en) * 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US5821230A (en) * 1997-04-11 1998-10-13 Ferring Bv GnRH antagonist decapeptides
EP0882736A1 (en) * 1997-06-02 1998-12-09 Laboratoire Theramex S.A. LH-RH peptide analogues, their uses and pharmaceutical compositions containing them
US6297354B1 (en) 1998-08-12 2001-10-02 Abbott Laboratories Pentapeptide LHRH antagonists
US6191115B1 (en) 1998-08-12 2001-02-20 Abbott Laboratories C-terminus modified heptapeptide LHRH analogs
US5981521A (en) * 1998-11-13 1999-11-09 Abbott Laboratories Tetrahydroisoquinoline derivatives as LHRH antagonists
US6455499B1 (en) 1999-02-23 2002-09-24 Indiana University Foundation Methods for treating disorders associated with LHRH activity
DE19911771B4 (de) 1999-03-17 2006-03-30 Zentaris Gmbh LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung
US6673352B1 (en) * 1999-09-14 2004-01-06 The General Hospital Corporation Use of Mullerian inhibiting substance for treating excess androgen states
RU2248982C9 (ru) * 2000-03-14 2005-06-10 Центарис Гмбх Антагонисты lhrh, их получение, фармацевтическая композиция и ее получение, способ лечения опухолей и бесплодия у млекопитающих
US20030176360A1 (en) 2000-07-05 2003-09-18 Yasutaka Igari Medicinal preparations for treating sex hormone-dependent diseases
US6598784B2 (en) * 2000-12-20 2003-07-29 Meadwestvaco Packaging Syatens, Llc Beverage carton with strap type carrying handle
CA2451187C (en) * 2001-06-22 2012-08-14 Southern Biosystems, Inc. Zero-order prolonged release coaxial implants
TWI225416B (en) 2001-06-29 2004-12-21 Takeda Chemical Industries Ltd Sustained-release composition and process for producing the same
US7098305B2 (en) * 2001-09-06 2006-08-29 Ardana Bioscience Limited Sustained release of microcrystalline peptide suspensions
WO2003041739A1 (en) 2001-11-13 2003-05-22 Takeda Chemical Industries, Ltd. Anticaner agents
US20050159361A1 (en) * 2002-03-11 2005-07-21 Takahito Hara Remedies for sex hormone-dependent disease
JP2004002321A (ja) * 2002-03-11 2004-01-08 Takeda Chem Ind Ltd 性ホルモン依存性疾患治療剤
AU2003262847A1 (en) * 2002-08-23 2004-03-11 The General Hospital Corporation Use of mullerian inhibiting substance and interferon for treating tumors
GB0326632D0 (en) 2003-11-14 2003-12-17 Jagotec Ag Dry powder formulations
US8882747B2 (en) * 2005-11-09 2014-11-11 The Invention Science Fund I, Llc Substance delivery system
EP2098507B1 (en) 2006-11-30 2014-11-12 Takeda Pharmaceutical Company Limited Cyclic amine compound as androgen receptor modulator
WO2010142060A1 (zh) * 2009-06-11 2010-12-16 中国人民解放军军事医学科学院毒物药物研究所 长效低组胺释放副作用的lhrh拮抗剂
EP2552424B1 (en) 2010-04-01 2018-05-09 Chiesi Farmaceutici S.p.A. Process for preparing carrier particles for dry powders for inhalation
US20130177651A1 (en) 2010-09-03 2013-07-11 Pharmaterials Limited Pharmaceutical Composition Suitable for Use in a Dry Powder Inhaler
WO2014010614A1 (ja) 2012-07-12 2014-01-16 武田薬品工業株式会社 マイクロカプセル粉末の製造方法
US20190298836A1 (en) 2016-11-02 2019-10-03 Board Of Regents, The University Of Texas System Dissolvable films and methods of their use

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU497512B2 (en) * 1975-04-15 1978-12-14 Ici Australia Limited Nona and deca-peptides
NZ188987A (en) * 1977-11-30 1982-02-23 Salk Inst For Biological Studi Peptide analogues of luteinizing hormone releasing factor
IT1149971B (it) * 1979-06-11 1986-12-10 Syntex Inc Derivati nonapeptide e decapeptide dell'ormone che rilascia l'ormone luteinizzante
US4493934A (en) * 1979-10-01 1985-01-15 Merck & Co., Inc. 2(3-Amino-2-oxopyrrolidin-1-yl) acetic acid and n-acylated derivatives thereof
US4444759A (en) * 1982-07-26 1984-04-24 The Salk Institute For Biological Studies GnRH Antagonists II
US4547370A (en) * 1983-11-29 1985-10-15 The Salk Institute For Biological Studies GnRH Antagonists
US4632979A (en) * 1984-06-18 1986-12-30 Tulane Educational Fund Therapeutic LHRH analogs
US4760053A (en) * 1984-08-02 1988-07-26 Fernand Labrie Combination therapy for selected sex steroid dependent cancers
US4690916A (en) * 1984-11-13 1987-09-01 Syntex (U.S.A.) Inc. Nona and decapeptide analogs of LHRH useful as LHRH antagonists
US4866160A (en) * 1985-04-09 1989-09-12 The Administrators Of The Tulane Educational Fund Therapeutic decapeptides
US5003011A (en) * 1985-04-09 1991-03-26 The Administrators Of The Tulane Educational Fund Therapeutic decapeptides
US4803261A (en) * 1986-06-27 1989-02-07 The Administrators Of The Tulane Educational Fund Method for synthesizing a peptide containing a non-peptide
US4801577A (en) * 1987-02-05 1989-01-31 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
US4851385A (en) * 1987-07-15 1989-07-25 Indiana University Foundation LHRH antagonist analogs having low histamine-release activity
US4935491A (en) * 1987-08-24 1990-06-19 Board Of Regents, The University Of Texas System Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine
ES2108684T3 (es) * 1988-02-10 1998-01-01 Tap Pharmaceuticals Inc Analogo de la hormona de liberacion de la hormona luteinizante (lhrh).
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
US5140009A (en) * 1988-02-10 1992-08-18 Tap Pharmaceuticals, Inc. Octapeptide LHRH antagonists

Also Published As

Publication number Publication date
AU5789294A (en) 1994-05-26
CA2022444C (en) 2002-01-15
US5110904A (en) 1992-05-05
JPH03101695A (ja) 1991-04-26
PT94924A (pt) 1991-05-22
PT94924B (pt) 1997-09-30
PL286388A1 (en) 1991-05-06
EP0413209A1 (en) 1991-02-20
IL95136A0 (en) 1991-06-10
AU6028690A (en) 1991-02-07
KR910004661A (ko) 1991-03-29
AU672474B2 (en) 1996-10-03
NO903455D0 (no) 1990-08-06
CA2022444A1 (en) 1991-02-08
KR0144144B1 (ko) 1998-07-01
IE902740A1 (en) 1991-02-27
HUT54387A (en) 1991-02-28

Similar Documents

Publication Publication Date Title
NO903455L (no) Analoger av frigjoeringshormon for luteiniserende hormon samt fremstilling derav.
MXPA99001870A (es) Antagonistas del receptor de taquicinina,no peptidicos.
IE812322L (en) Nonapeptides and decapeptides
MX9705273A (es) Inhibidores de prenil transferasas.
MX9703186A (es) Antagonistas del receptor del neuropeptido y de indolilo.
UA39099C2 (uk) Циклічні азотовмісні похідні, суміш їх ізомерів або окремі ізомери, або їх солі
NO951613L (no) Ikke-peptidyl tachykinin reseptorantagonister
DK0831100T3 (da) Nye peptidderivater
EE9800173A (et) Gonadotropiini riliisinghormooni antagonistid
NO992878L (no) Indolin-2-on-derivater, fremgangsmåte for fremstilling av dem og farmasöytiske blandinger som inneholder dem
MX9304698A (es) Heterociclos que contienen nitrogeno substituido.
HUP0100353A2 (hu) Urokináz inhibitor hatású naftamidinszármazékok
DE69732120D1 (de) Trizyklische inhibitoren der farnesyl protein transferase
DE69419623T2 (de) Peptidinhibitoren der urokinaserezeptor-aktivität
NO963370L (no) Nye mercaptoacetylamido-1,3,4,5-tetrahydrobenzo[cÅazepin-3-on-disulfidderivater som er anvendbare som inhibitorer av enkefalinase og ACE
ES8604265A1 (es) Un metodo para preparar un peptido o una sal no toxica del mismo.
PL322326A1 (en) Derivatives of nodulisporic acid
NO933524D0 (no) Krystallisk tiagabinhydrokloridmonohydrat samt fremstilling og anvendelse derav
EP0328090A3 (en) Lhrh analogs
DK0608336T3 (da) Azabicycloarylacetylen- og -arylenynoximer som cholinerge midler og fremgangsmåde til behandling
IL110392A0 (en) 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
TR199800243T1 (xx) Prolil endopeptidaz inhibit�rleri.
MY105128A (en) Bu-3608 derivatives.
ATE209201T1 (de) Substituierte benzocycloheptapyridine derivate verwendbar als farnesyl-protein transferase inhibitoren
ES453927A1 (es) Un procedimiento de obtencion de nuevas difenilacetamidas.